Alison Maxwell Walters
About Alison Maxwell Walters
Alison Maxwell Walters is a Senior Regulatory Affairs Associate with extensive experience in the animal health sector, currently working at Dechra Pharmaceuticals PLC in Australia. She has a strong background in regulatory processes, having registered various product ranges in both Australia and New Zealand.
Work at Dechra Pharmaceuticals
Alison Maxwell Walters has been employed at Dechra Pharmaceuticals PLC as a Senior Regulatory Affairs Associate since 2021. In this role, she applies her extensive knowledge and experience in regulatory affairs to ensure compliance with industry standards and regulations. Her responsibilities include managing regulatory submissions and maintaining product registrations, contributing to the company's mission of providing high-quality animal health products.
Previous Experience in Regulatory Affairs
Prior to her current position, Alison held various roles in regulatory affairs across multiple organizations. She worked at Troy Animal Healthcare as a Senior Regulatory Affairs Associate from 2019 to 2021. Before that, she spent several years at Virbac, where she progressed from a QA Associate to a Senior Regulatory Affairs Associate between 2012 and 2019. Additionally, she worked at Parnell Veterinary Pharmaceuticals and International Animal Health Products, gaining a comprehensive understanding of regulatory processes in the animal health sector.
Education and Expertise
Alison Maxwell Walters earned her Bachelor of Science in Medicinal and Pharmaceutical Chemistry from the University of New South Wales (UNSW) between 1998 and 2002. Her educational background provides a strong foundation for her expertise in regulatory affairs, particularly in the management and use of stability systems and data, which are essential for ensuring the quality and efficacy of pharmaceutical products.
Achievements in Regulatory Processes
Alison has demonstrated her expertise in regulatory processes by successfully registering the Milpro range in Australia and the Glyde range of joint health products in New Zealand. These accomplishments highlight her proficiency in navigating both domestic and international regulatory environments, showcasing her ability to manage complex regulatory submissions effectively.